ClinicalTrials.gg
Status unknownNCT04532827DigiPimoUpdated Jan 4, 2023

Web-based Rehabilitation for Persistent Physical Symptoms.

An interventional study of Case formulation with web-program in Persistent Physical Symptoms, Indoor Environment Associated Symptoms and Indoor Air Associated Symptoms, sponsored by Finnish Institute of Occupational Health. Status unknown at 1 site in Finland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-01-04.

Sponsored by Finnish Institute of Occupational Health · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Persistent physical symptoms (PPS) might diminish studying or workability and daily functioning without a clear medical or environment-related explanation. Psychosocial, patient-involving treatments that support individuals' abilities managing with the PPS and health behaviours have shown promising effects in treating PPS but the acceptability of these treatments among symptomatic individuals is low.

This study aims to assess the effectiveness of an eHealth intervention based on relational frame theory and acceptance and commitment therapy on PPS with two focus groups, among participants with indoor air associated disabling symptoms or persistent, chronic fatigue.

This study will compare web program enhanced with video-based individual case formulation with treatment as usual. The web program includes 10 one weeks (pilot included 6 two weeks) modules. In addition to patient-reported outcomes, ecological momentary assessments are conducted to provide real-time data on functioning and national registers are used to obtain information on health-care use and social benefits.

Data collection begins in August 2020 and will continue until 2023.

Read the detailed description

Background: Frequent physical symptoms are common in the general population with over 90 per cent of the population reporting symptoms at some level. In some cases, they become persistent diminishing workability and daily functioning and associate with increased healthcare usage and sick leaves independently of other somatic or psychiatric comorbidities. Persistent physical symptoms (PPS) challenge health care systems as it is estimated that up to 4-30 per cent of primary health care visits are due to PPS without a clear medical explanation. Psychosocial, patient-involving treatments, such as cognitive-behavioural psychotherapy (CBT), that support individuals' abilities managing with the PPS and health behaviours have shown promising effects in treating PPS but so far, evidence-based treatments have resulted only in small to moderate effect sizes. The acceptability of these treatments among symptomatic individuals is also low - presumably because of the stigma related to the ambiguity of the PPS´ status as a medical condition. A stronger orientation to personalized treatment protocols is needed to improve the treatment efficacy and applicability.

This study will assess the effects of an eHealth intervention based on relational frame theory and acceptance and commitment therapy on PPS with two focus groups, among participants with indoor air associated disabling symptoms or persistent, chronic fatigue.

Methods: Using a randomized controlled design (RCT) with two parallel groups in a 1:1 ratio, the investigators will compare ACT/RFT-based web program enhanced with individual case formulation with treatment as usual. The web program intervention includes 10 one weeks (pilot included 6 two weeks) modules that each ask to complete the module and included training in two weeks. The web program is in Finnish. Participants will be asked to complete outcome questionnaires at baseline before the interview for inclusion, after the interview (randomization) and at 3, 6- and 12-months' follow-up after the randomization. The intervention group receives also a questionnaire four weeks after the beginning of the web program. In addition, ecological momentary assessments are also conducted to provide real-time data on functioning and national registers are used to obtain information on healthcare use and social benefits to complete patient-reported outcomes.

Eligible participants will be randomized to either the intervention or to TAU. The primary outcome will be a health-related quality of life. The secondary outcome measures are symptoms, illness perceptions, psychological flexibility and workability. Further, the investigators will assess whether any effect of the intervention on the primary outcome is mediated by the case formulation. The baseline data collection begins in August 2020 and will continue until 2022, follow-up data collection will continue until 2023.

02

Conditions studied

  • Persistent Physical Symptoms
  • Indoor Environment Associated Symptoms
  • Indoor Air Associated Symptoms
  • Chronic Fatigue Syndrome

Keywords

  • Indoor air
  • Persistent physical symptoms
  • Chronic Fatigue Syndrome
  • Web-based intervention
  • Rehabilitation
  • Indoor environment
  • EHealth
03

In context

Fatigue Syndrome, Chronic

265 studies on the registry are indexed under Fatigue Syndrome, Chronic; 63 are open to participants now.

This study's enrollment of 105 is above the median of 60 across 179 interventional studies indexed under Fatigue Syndrome, Chronic.

Browse Fatigue Syndrome, Chronic studies →

Lead sponsor

Finnish Institute of Occupational Health is the lead sponsor of 13 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fluent Finnish (web-program is in Finnish)
  • Duration of the symptoms Onset of symptoms with disability maximum of 3 years before the study
  • Symptomatology A) Indoor air-related symptoms or B) Persistent, chronic fatigue

A) Indoor air-related symptoms

  1. Self-reported symptoms attributed to indoor (non-industrial) environments include: i) symptoms from at least two different organ systems eg. respiratory, digestive or nervous system.
  2. Symptoms recurrently i) occur in more than one indoor environment or ii) continue despite environmental improvements (e.g. study or work arrangements and/or workplace repairs)

or

B) Chronic fatigue

  1. Post-exertional malaise and/ or post-exertional fatigue.
  2. Unrefreshing sleep or disturbance of sleep quantity or rhythm disturbance.
  3. Multiorgan symptoms i) Pain, often widespread, ii) Two of more neurological or cognitive symptoms, iii) At least two symptoms of following categories: Autonomic manifestations, neuroendocrine manifestations or immune manifestations

    • Duration and severity of the condition: Symptoms minimum of six months; Symptoms are not lifelong and result in substantial functional restrictions in daily life.

Exclusion criteria

Exclusion Criteria:

  • Work situation: Long sick leave (≥3 months) without return to work plan, not actively participating in study or work life (retired or unemployed)
  • Medical reasons

    1. Some serious and/or acute medical disease or illness explains the symptoms i) Somatic disease that explains the symptoms (e.g. uncontrolled asthma, hypothyroidism, sleep apnea)
    2. Psychiatric disorder (bipolar disorder, psychotic disorders, alcohol and/or drug dependency or abuse, eating disorders, and/or severe mood disorders)
    3. Developmental disorders
  • Current psychotherapy
  • Other Patient refusal
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    Case formulation with web-program

    The intervention will start with two video meetings with a psychologist to build up and present an individual case formulation, based on behavioural analysis, and to build up a shared decision of individual goals for the web program. The intervention continues with a web program consisting of ten manualized web-based modules, each at one-week intervals based on relational frame theory (RFT) and acceptance and commitment therapy (ACT). The pilot programme included six two-weeks modules and it was in use until 5/2021. The programme is in Finnish. Both participants in the intervention arm and in the treatment as the usual arm will receive usual care, meaning that TAU will be enhanced with the study intervention in the intervention arm. In addition to TAU, all participants will be given self-help and educational leaflet based on scientific knowledge related to their condition.

    Behavioral: Case formulation with web-program

  • No intervention
    Treatment as usual

    Treatment as usual includes all the routine care that individual receives when he or she is presenting his or her symptoms at the primary or the occupational health care unit (corresponds primary care level treatment) or other unit that recommends the study for the participant. In practice, TAU may vary between the study participants based on their individual needs e.g. treatments for co-morbid somatic diseases or psychiatric disorders that this study will not interfere. Both participants in the intervention arm and in the treatment as usual arm will receive usual care, meaning that TAU will be enhanced with the study intervention in the intervention arm. In addition to TAU all participants will be given self-help and educational leaflet based on scientific knowledge related to their condition.

Interventions

  • BehavioralCase formulation with web-program

    The first meeting includes an interview to establish understanding on the participant´s symptomatology and current life situation, a case formulation (CF) will be build based on it. The CF is presented in the second session and modifications can be made to ensure acceptability for the participant. Goals for web program (WB) are set based on the CF and understanding of the factors contributing to the participant´s wellbeing. WB modules are instructed to complete during the week. Modules include psychoeducation, experiential exercises and training aimed at improving wellbeing and psychological flexibility. Web-therapist will offer written feedback. The participants can contact the therapist via the WB and al messages will be replied within one week. Automatic reminders will be sent if a participant has not been active in the WB, the therapists will call participants who have discontinued using the WB.

06

What researchers measure

Primary outcomes

  1. The 15D questionnaire (health related quality of life)

    The 15D is a utility-based generic, standardized measure, comprising the following 15 dimensions that describe physical, mental, and social well-being: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, usual activities, mental function, discomfort and symptoms, depression, distress, vitality, and sexual activity. Each dimension is graded by the respondent on a scale ranging between 1 and 5, where 1 indicates an experience of no problems at all with the dimension and 5 indicates severe problems. Thus, the 15D can be used to measure a vast number of health states. We will use the 15D data both to derive 15D overall scores with values from 1 (full health) to 0 (being dead), and to obtain dimensional symptom profiles.

    Time frame: Chance from baseline (i.e. at self-referral) to after randomisation (i.e. after clinical assessment), and to 6 and 14 weeks and to 6 and to 12 months after randomisation

Secondary outcomes

  1. Demographic questions: age (years)

    Time frame: At baseline (i.e. at self-referral)

  2. Demographic questions: gender (male, female, prefer not to say)

    Time frame: At baseline (i.e. at self-referral)

  3. Demographic questions: marital status (Unmarried, married or cohabiting, divorced or separation, widow)

    Time frame: At baseline (i.e. at self-referral)

  4. Demographic questions: education (basic, secondary, higher)

    Time frame: At baseline (i.e. at self-referral)

  5. Demographic questions: daily exercise

    One item of the frequency of the exercise on a six point likert scale (No weekly exercise - 4 times/week or more)

    Time frame: At baseline (i.e. at self-referral)

  6. Demographic questions: Diet

    Two items of the diet on a six point likert scale (have daily regular eating habits - have no regular eating habits; Caffeine consumption never - 7 or more proportion per day)

    Time frame: At baseline (i.e. at self-referral)

  7. Social support and loneliness

    Five questions of frequency of perceived loneliness and and social support in challenging situations (likert scale).

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  8. Smoking, Alcohol Use Disorders Identification Test (Audit-C)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  9. Questions about health: Self-reported health

    Five point likert scale (very poor - very good)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  10. Questions about health: Self-reported diseases (diagnosed by medical doctor)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  11. Questions about health: medication

    Self-reported medication during past four weeks (name, dose, purpose of use)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  12. Questions about health: Health care unit

    An open question of the participant´s health care provider.

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  13. Questions about health: Information seeking

    Questions about health information seeking from different sources (on a six point likert scale)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  14. Questions about health: height in meters

    height in meters to calculate BMI kg/m\^2

    Time frame: At baseline (i.e. at self-referral)

  15. Questions about health: weight in kilograms

    weight in kilograms to calculate BMI kg/m\^2

    Time frame: At baseline (i.e. at self-referral)

  16. Work characteristics

    Questions about participant work characteristics (working hours, field of industry etc)

    Time frame: At baseline (i.e. at self-referral), and 12 months after randomisation

  17. Symptoms related to environmental factors

    Questions whether environmental factors such as mold or water damage in buildings, electromagnetic fields, chemicals or indoor air have associated with symptoms and have they associated with avoidance behavior (yes - no).

    Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and 6 and 12 months after randomisation

  18. Health worries and health worries related to environmental factors

    Questions about health worries in general and related to environmental factors (scale 0 not worried at all - 10 extremely worried)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  19. Environmental factors: influence on everyday life

    Questions about the influence of environmental factors on everyday life (scale 0 no consequences - 10 severe consequences)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  20. Resiliency (SOC-3)

    Time frame: Time Frame: At baseline (i.e. at self-referral)

  21. Personality Inventory (PK5)

    Time frame: Time Frame: At baseline (i.e. at self-referral)

  22. Questions about sleep quality, sleeping patterns

    Length of sleep (weekdays and weekends, hours)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and, 6 and 12 months after randomisation

  23. Questions about sleep quality, sleeping patterns

    Nap (frequency per week and length, hours)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  24. Questions about sleep quality, sleeping patterns

    Self-reported i) sleep quality, ii) night awakening iii) sleep disorders and iv) frequency of sleeping medicine usage at five point likert scale.

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  25. Questions about sleep quality, sleeping patterns

    Self-reported quality of rest and rhythmicity at four point likert scale.

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  26. Fatigue

    Questionnaire about perceived fatigue and its´consequences on daily functioning during past six months.

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  27. Generalized Anxiety Disorder 7 (GAD-7)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  28. Insomnia Severity Index (ISI)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  29. Patient Health Questionnaire-15 (PHQ-15)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  30. The Patient Health Questionnaire (PHQ-9)

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, and 6 and 12 months after randomisation

  31. AIDO Healthcare app: daily mood and fatigue

    Time frame: 1.5, 3.5 and 12 months after randomisation

  32. The Acceptance and Action Questionnaire -II AAQ-7

    Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and, 6 and 12 months after randomisation

  33. Comprehensive assessment of Acceptance and Commitment Therapy CompACT

    Time frame: At baseline (i.e. at self-referral), and 14 weeks, 6 and 12 months after randomisation

  34. Cognitive Fusion Questionnaire (CFQ-7)

    Time frame: At baseline (i.e. at self-referral), and 6 and 14 weeks and, 6 and 12 months after randomisation

  35. Whiteley index -7 questionnaire

    Time frame: At baseline (i.e. at self-referral), and 14 weeks and 6 and 12 months after randomisation

  36. White Bear Suppression Inventory (WBSI)

    Time frame: At baseline (i.e. at self-referral), after randomization and 14 weeks and, 6 and 12 months after randomisation

  37. Five Facet Mindfulness Questionnaire (FFMQ)

    Time frame: At baseline (i.e. at self-referral), after randomization and 12 months after randomisation

  38. Toronto alexithymia scale (TAS-20)

    Time frame: At baseline (i.e. at self-referral)

  39. Illness Perception Questionnaire

    Time frame: At baseline (i.e. at self-referral) and 6 and 14 weeks and 6 and 12 months after randomisation

  40. Self-assessed current ability to study or work

    One question about current ability to study or work on a scale 1-10.

    Time frame: At baseline (i.e. at self-referral) and 14 weeks 6 and 12 months after randomisation

  41. Own prognosis of ability to study or work two years from now

    One question about of work ability two years from now (scale Unlikely; Not certain; Relatively certain)

    Time frame: At baseline (i.e. at self-referral) and 14 weeks 6 and 12 months after randomisation

  42. Self-assessed stress and recovery

    One question about stress and recovery on a scale 1-10.

    Time frame: At baseline (i.e. at self-referral) and 14 weeks and 6 and 12 months after randomisation

  43. Daily functioning in three sub-domains.

    Three questions about daily functioning (work, social life, home) on a scale 1-10 each

    Time frame: At baseline (i.e. at self-referral and 14 weeks and 6 and 12 months after randomisation

  44. Working Alliance Inventory (WAI) - patient version for eHealth intervention

    Time frame: after randomization and 6 and 14 weeks after randomisation

  45. Treatment satisfaction

    Six items of treatment satisfaction based on Seligman´s report (1995). The effectiveness of psychotherapy: The Consumer Reports study. American psychologist, 50(12), 965.

    Time frame: after randomization and 6 and 14 weeks after randomisation

Other outcomes

  1. Interview of treatment acceptance

    Interview for sample of intervention participants about the treatment acceptance (qualitative)

    Time frame: 12 months randomisation

  2. Engagement to the intervention

    Total number of logins and time during the web-program, modules and exercises completed.

    Time frame: 14 weeks after randomisation.

  3. Reasons for discontinuing

    If participant discontinues he / she will be contacted.

    Time frame: Through study completion, an average of 1 year

  4. The Finnish national health registers

    The Finnish national health registers to assess health care expenditures: Data on outpatient visits (AvoHILMO data), data on inpatient care (HILMO data), data on occupational health care use, information on prescribed and reimbursed prescription medicines purchases, information on rights for special reimbursement for medicines and information on sickness and disability benefits and rehabilitation with diagnoses

    Time frame: At baseline (i.e. at self-referral), at 12 months after randomisation

07

Study locations

1 site
  • Finnish Institute of Occupational Health
    Helsinki, Uusimaa 00270, Finland
08

References and documents

Individual participant data

Plan to share: No — All IPD that underlie results in a publication could be published But: study participants choose in informed consent that do they accept that their IPD will be published (anonymized). If they choose 'no´, their data won´t be published. Thus the preliminary plan is not to share the IPD (´undecided' would be accurate as well).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2020 (actual). Primary completion is estimated for Jul 2023, 34 months after the start.

Of 73 non-industry interventional studies with no phase under Fatigue Syndrome, Chronic, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 34 months is above that.

Counting every sponsor, half of 78 studies reached it within 23 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2020
First posted
Aug 31, 2020
StartActual
Aug 18, 2020
Primary completionEst.
Jul 1, 2023
CompletionEst.
Sep 30, 2023
Last update
Jan 4, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04532827
Lead sponsor
Finnish Institute of Occupational Health
Collaborators
The Social Insurance Institution of Finland, the Hospital District of Helsinki and Uusimaa
Responsible party
Sponsor
First posted
Aug 31, 2020
Start date
Aug 18, 2020
Primary completion
Jul 1, 2023 (estimated)
Completion
Sep 30, 2023 (estimated)
Last update
Jan 4, 2023

Study contacts

Tiina Paunio, Professor
principal investigator · University of Helsinki, Finnish Institute of Occupational Health, the Hospital District of Helsinki and Uusimaa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion